MODEL organisms are widely employed in mechanistic studies of human Mendelian disease ([@bib2],[@bib3]; [@bib15]; [@bib40]; [@bib51]; [@bib57]; [@bib62]; [@bib38]). They are likewise an important resource for investigating the genetic underpinnings of continuously varying quantitative traits ([@bib53]; [@bib71]; [@bib74], [@bib75]; [@bib17]; [@bib6]; [@bib23]; [@bib1]; [@bib18]; [@bib26]; [@bib45], [@bib43], [@bib44]). Numerous models of human disease have been established in the fly (reviewed in [@bib54]), including transgenic models of diseases ranging from neurodegeneration/retinal degeneration ([@bib7]; [@bib60]; [@bib38]; [@bib80]) to cancer ([@bib59]). Success with genetic screens to identify suppressors and enhancers of disease when mutants are overexpressed in a developing tissue, such as the eye-antennal imaginal disc, suggested to us that it might be possible to generate a fly model of misfolded insulin-associated diabetes.

A number of dominant mutations in human proinsulin have been identified in patients with permanent neonatal diabetes ([@bib67], [@bib68]). One class of these involves mutations leading to an unpaired cysteine. The mutation of Cys-96 to Tyr---hINS^C96Y^---abolishes a disulfide bridge between the A and B chains of the polypeptide, causing proinsulin to misfold and accumulate in the endoplasmic reticulum (ER). Induction of the unfolded protein response (UPR), caused by ER stress, ultimately leads to pancreatic β-cell death ([@bib52]; [@bib28]). Mutant insulin-induced diabetes may also be a model for the more common type 2 (adult onset) form of diabetes, where increased demand for insulin overwhelms the pathways regulating protein folding and trafficking. In this case, the accumulation of misfolded wild-type proinsulin in the ER is hypothesized to trigger pathways that respond to loss of proteostatic control ([@bib52]; [@bib61]).

Many signaling mechanisms regulating proteostasis---the dynamics of protein expression and turnover including folding, processing, transport, regulation, and degradation---are conserved between fly and human ([@bib22]; [@bib35]; [@bib29]; [@bib9]). Misfolded alleles of rhodopsin, for example, cause age-related retinal degeneration in both species. In the fly model, overexpression of *[ninaE](http://flybase.org/reports/FBgn0002940.html)* (a mutant allele of the fly ortholog of human rhodopsin-1) in the eye-antennal imaginal disc induces ER stress-associated UPR and pro-apoptotic signaling, resulting in adult-onset eye degeneration ([@bib60]; [@bib33]; [@bib47]; [@bib34]). Strongly conserved signaling mechanisms in these pathways led us to reason that overexpression of mutant human preproinsulin (hINS^C96Y^) in the fly would likewise unleash UPR and cell death, thus recapitulating biological processes acting in the human form of the disease.

To test this prediction we created a transgenic model of permanent neonatal diabetes in the fly by expressing hINS^C96Y^ under regulatory control of the UAS-Gal4 system. We drove hINS expression in larval/pupal imaginal discs, precursors of adult structures, and measured the loss of adult tissue, expected if the mutant activated cell death pathways. We also examined phenotypes in flies expressing wild-type human preproinsulin (hINS^WT^) as a control. Here we describe phenotypic characteristics of this Mendelian model of disease, including sex-specific differences, dosage, environmental sensitivity, and reorganization of gene expression.

In addition, we examined dominant and partially dominant genetic variation in disease severity by crossing a panel of inbred lines derived from a natural population sample \[*Drosophila* Genetic Reference Panel (DGRP)\] ([@bib46]) to a tester stock carrying both the mutant insulin transgene and an eye imaginal disc-specific Gal4 expression driver on the same chromosome (GMR\>\>hINS^C96Y^). With *Drosophila* having 20--40 times greater density of single-nucleotide polymorphisms (SNPs) than human and being genetically variable for most phenotypic traits, we expected this genetic screen to expose abundant genetic variation for the severity of disease phenotypes. Measuring the effects of natural modifiers in outcrossed flies avoids inbreeding effects in the isogenic lines and better mimics their heterozygosity in natural populations, especially low-frequency variants. Repeated measurements of genetically identical F~1~ flies also reduce nongenetic variance components compared to individual measurements, increasing the power to detect genetic differences ([@bib45]). By examining adult eye reduction in F~1~ flies, we quantify disease phenotypes in different genetic backgrounds and describe its distribution of effects in a natural population sample.

We then investigated biological properties of the naturally occurring genetic variation unleashed by our model of proteostatic disease. We first determine the correlation structure of hINS^C96Y^-induced phenotypes in the adult eye and notum when hINS^C96Y^ is expressed in their respective imaginal discs in a set of DGRP lines. We provide evidence for different alleles or loci modifying the disease in the two tissues, contrary to our expectation that the same alleles would be acting. This result led us to investigate genetic variation acting in eye-specific developmental pathways. We measured eye reduction in the same DGRP lines in crosses to two classical dominant eye mutants, *[Drop](http://flybase.org/reports/FBgn0000492.html)* (*[Dr](http://flybase.org/reports/FBgn0000492.html)*) and *[Lobe](http://flybase.org/reports/FBgn0001332.html)* (*[L](http://flybase.org/reports/FBgn0001332.html)*), and found that both are also uncorrelated with eye reduction induced by hINS^C96Y^ expression. The presence of tissue- and disease-specific modifiers in our model of a human Mendelian disease affirms the suitability of *Drosophila* as a model for investigating genetically complex forms of human disease.

Materials and Methods {#s1}
=====================

*Drosophila* stocks {#s2}
-------------------

The *Drosophila* stocks used in this study are described in [Table 1](#t1){ref-type="table"}.

###### *Drosophila* stocks

  Stock                                                           Genotype                                                  Reference or source                Comment
  --------------------------------------------------------------- --------------------------------------------------------- ---------------------------------- -------------------------------------------------------------------------------------
  hINS transgene                                                                                                                                               
   WT-24; WT-6                                                    P(UAS-hINS^WT^)w1118 background                           This study                         Wild-type human proinsulin; second chromosome insertion site
   M-1; M-101                                                     P(UAS-hINS^C96Y^)w1118 background                         This study                         Mutant human proinsulin; second chromosome insertion site
  Gal4 drivers                                                                                                                                                 
   GMR-Gal4                                                       w\*; P{Gal4-ninaE.GMR}12                                  1104 (Bloomington Stock Center)    Expresses in eye disc morphogenetic furrow
   ap-Gal4                                                        ap-Gal4/CyO                                               25686 (Bloomington Stock Center)   Expresses in developing mesothorax (notum)
   en-Gal4                                                        en-Gal4 ciBe/CyO Act5c-GFP                                R. Fehon                           Expresses in ventral compartment of wing imaginal disc
   dpp-Gal4                                                       dpp^blnk^-Gal4, UAS-GFP^NLS^/TM6B                         R. Fehon                           Expresses between dorsal and ventral compartments of wing imaginal disc
  \[Gal4 driver\], \[hINS\]; Gal-4 driver, hINS same chromosome                                                                                                
    GMR\>\>hINS^WT^,  GMR\>\>hINS^C96Y^                           w1118; GMR-Gal4, UAS-hINS^WT^ *^or\ C96Y^*, UAS-GFP/CyO   This study                         GMR-Gal4 driver recombined onto hINS-bearing chromosome (WT-24 or M-1)
    ap\>\>hINS^WT^,  ap\>\>hINS^C96Y^                             w1118; ap-Gal4, UAS-hINS^WT^ ^or^ *^C96Y^*/CyO            This study                         ap-Gal4 driver recombined onto hINS-bearing chromosome (WT-24 or M-1)
  Other stocks                                                                                                                                                 
   *Drop* (*Dr*)                                                  w1118; Dr1/TM3, twist-GFP                                 R. Fehon                           Reduced eye size; acts through Jak/Stat pathway in ventral eye development
   *Lobe* (*L*)                                                   L(1)                                                      318 (Bloomington Stock Center)     Muscle segment homeobox-1 transcription factor; induces apoptosis in developing eye
   Scutoid (Sco)                                                  w1118; CyO dfd- YFP/sna^Sco^                              R. Fehon                           Missing bristles on notum
   DGRP                                                           Inbred wild lines                                         Bloomington Stock Center           "Core 38 " used in these experiments

Crosses {#s3}
-------

Flies were maintained on standard commercial medium at 25°. Mutant and wild-type hINS phenotypes, including adult and imaginal disc morphology and gene expression, were examined in F~1~ flies produced by crosses between stocks carrying a hINS transgene (M-1 or WT-24) and a tissue-specific Gal4 driver (GMR-Gal4, ap-Gal4, en-Gal4, or dpp-Gal4). To examine hINS phenotypes in outcrossed genetic backgrounds, we crossed DGRP inbred stocks with a "tester" stock in which a Gal4 driver (GMR-Gal4 or ap-Gal4) was recombined onto a second chromosome carrying a hINS transgene (designated GMR\>\>hINS or ap\>\>hINS; [Table 1](#t1){ref-type="table"}). For each cross, and also crosses between DGRP stocks and *[L](http://flybase.org/reports/FBgn0001332.html)* or *[Dr](http://flybase.org/reports/FBgn0000492.html)*, 5 healthy virgin females from the tester stock were mated with 5--10 healthy males from each the DGRP stocks. Parents were transferred to fresh culture bottles every 2 days for 8 days. Phenotypes were measured separately in a minimum of 10 individuals for each sex. Eye measurements were made on 3- to 5-day-old adults only. This particular trait, however, is stable in adults and has good replicability ([Supporting Information](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/157602SI.pdf), [Figure S1](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/FigureS1.pdf)). The crosses between the tester stock and DGRP stocks were generally carried out in a single block to minimize experimental error.

Transgene construction and *P*-element-mediated transformation {#s4}
--------------------------------------------------------------

The Gal4/UAS system ([@bib66]) was used for ectopic gene expression of the wild-type and mutant (C96Y) human preproinsulin. Transgenic human preproinsulin wild-type (hINS^WT^) and mutant (hINS^C96Y^) flies were generated by subcloning the human preproinsulin cDNA ([@bib4]) into the *Drosophila* transformation vector pUAST (<https://dgrc.cgb.indiana.edu/product/View?product=1000>). Transformation was carried out as described in [@bib65]. Mapping crosses are described in [@bib42]. For the UAS-hINS^WT^ and UAS-hINS^C96Y^ constructs, we generated 8 and 19 independently transformed stocks, respectively, each of which contained a single transposon insertion. For each of two constructs (WT and C96Y) at least one insertion in each of the three major chromosomes of *Drosophila melanogaster* was generated to control for the influence of position effect on transgene expression.

Immunohistochemistry {#s5}
--------------------

*Drosophila* third instar wandering larvae of either sex were dissected in phosphate-buffered saline (PBS). Isolated discs (approximately five pairs per sample) were placed in a glass tube with 4% paraformaldehyde in PBS and incubated for 30--40 min at room temperature. Discs were then washed three times in PBS, 5 min each, and treated with 1% Triton X-100 in PBS for 30 min at room temperature. Discs were washed again three times in PBS for 5 min each and treated with 5% normal donkey serum (NDS) in PBS. Staining with a mixture of mouse anti-human C peptide (Millipore, Bedford, MA; 1:200) and rat anti-ELAV (Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA; 1:200) was performed in PBS with 1% NDS. Secondary antibodies were from Jackson ImmunoResearch. After staining, imaginal discs were removed with a glass pipette coated with NDS, placed in a drop of SlowFade Gold with DAPI (Invitrogen, Carlsbad, CA) antifade solution, and covered with a glass coverslip. Staining was observed with a Leica SP2 laser scanning confocal microscope with 20× or 63× objectives.

Transcriptional profiling {#s6}
-------------------------

Total RNA from 12 eye imaginal discs from each stock was isolated from wandering third instar larvae, using the MELT Total Nucleic Acid Isolation System (Ambion, Life technologies). The quality and quantity of each RNA sample were checked using a 2100 BioAnalyzer (Agilent Technologies) and Nanodrop 1000 (Thermo Scientific). Amplification of total RNA and synthesis of cDNA were carried out using the Ovation RNA Amplification System V2 (NuGen Technologies) from 100 ng of total RNA. The amplified cDNA was purified using a Zymo-Spin II Column (Zymo Research Clean and Concentrator-25; Zymo Research). Totals of 3.75 μg of fragmented and labeled single-stranded cDNA targets were generated by the FL-Ovation cDNA Biotin Module V2 (NuGen Technologies) and hybridized to each Affymetrix-GeneChip *Drosophila* Genome 2.0 Array. Four microarrays were used to estimate transcript levels for the F~1~ progenies from five crosses (two males and two females each): control (GMR-Gal4 × w1118) expressing the Gal4 activator protein only, hINS^WT^ line 6 (GMR-Gal4 × WT-6), hINS^WT^ line 24 (GMR-Gal4 × WT-24), hINS^C96Y^ line 101 (GMR-Gal4 × M-101), and hINS^C96Y^ line 1 (GMR-Gal4 × M-1). The two lines of each genotype, hINS^WT^ or hINS^C96Y^, were selected to represent moderate and high expression of the hINS transgene. Microarray data are available at the Gene Expression Omnibus (GEO) (<http://www.ncbi.nlm.nih.gov/geo>) under accession no. GSE43128.

Analysis of microarray data {#s7}
---------------------------

Intensity data for each feature on the array were calculated from the images generated by the GenChip Scanner 3000 7G (Affymetrix) and the data files were extracted using GeneChip Operating Software (MicroArray Suite 5.0 software; Affymetrix). We performed background subtraction and normalization of CEL files both in dChip (2010.1) software with its default parameter (fifth percentile of perfect match probes as baseline for background subtraction, invariant set for normalization).

### Data analysis 1: {#s8}

We used Partek software (v6.5) initially to identify differentially expressed genes in the comparison between GMR-Gal4 background and each transgenic fly (GMR-Gal4/UAS-hINS^WT^ or INS^C96Y^, four genotypes). Sexes were analyzed separately. A one-way ANOVA was performed with genotype as a fixed effect. All genes for which the effect of genotype was significant at a false discovery rate (FDR) of 10% were further tested to determine whether mean expression of GMR-Gal4/UAS-hINS^WT^ or GMR-Gal4/UAS-hINS^C96Y^ was significantly different from that of the control (GMR-Gal4).

### Data analysis 2: {#s9}

The normalized intensity data were log2 transformed for subsequent analyses implemented using R-bioconductor (v 2.10.0). To compare the transcriptional responses to the expression of wild-type or mutant hINS, we restricted the analysis to a single pair of the transgenic lines, WT-24 and M-1, matched for high level of hINS expression based on quantitative real-time (qRT) PCR, together with the control (GMR-Gal4), and performed independent ANOVA for each array feature under the model *Y~ijk~* = *u* + *L~i~* + *S~j~* + *e~ijk~*, where *L~i~* is line (*i* = 1, 2 or 3), *S~j~* is sex (*j* = 1 or 2), and *e~ijk~* is error (*k* = 1 or 2). We applied the Benjamini and Hochberg procedure ([@bib5] [@bib5]) on the resulting *P*-values to control the FDR.

Quantitative real-time PCR {#s10}
--------------------------

Total RNA was isolated from heads of 30 adult flies, using Trizol reagent (Invitrogen, Life Technologies), and from eye-antennal imaginal discs from 12 wandering third instar larvae, using the MELT Total Nucleic Acid Isolation System (Ambion). cDNA synthesis was performed using oligo(dT) primer and the Superscript III First-Strand Synthesis System (Invitrogen). qRT-PCR was carried out using a StepOneReal-Time PCR System (Applied Biosystems Inc., Life Technologies) in triplicate. Gene-specific sets of primers ([Table S1](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/TableS1.pdf)) and SYBR green PCR master mix (Applied Biosystems Inc.) were used to quantify gene expression. Results were normalized to the expression of *rp49*.

Analysis of XBP1 mRNA splicing {#s11}
------------------------------

Total RNA was isolated from wandering third instar larvae and cDNA synthesized, as described above. To visualize the alternative splicing of the 23-bp XBP1 intron, a diagnostic marker of UPR induction ([@bib16]; [@bib48]; [@bib63]; [@bib79]), PCR was carried out using the *D. melanogaster*-specific primers 5′-AACAGCAGCACAACACCAGA-3′ (forward) and 5′-CGCCAAGCATGTCTTGTAGA-3′ (reverse), which amplifies fragments of 239 bp for unspliced XBP1 (U) and 216 bp for spliced XBP1 (S). The PCR conditions were initial denaturation at 94° for 3 min; 35 cycles of denaturation at 94° for 30 sec, annealing at 57° for 30 sec, and extension at 72° for 1 min; and a final extension at 72° for 10 min. PCR products were separated by 10% PAGE and visualized by ethidium bromide staining. PCR products were also digested with *Pst*I to better distinguish the spliced and unspliced forms of XBP1 mRNA.

Eye measurement {#s12}
---------------

Low-magnification images were captured with a Zeiss (Carl Zeiss, Thornwood, NY) AxioCam HRc mounted on a Leica MZ16 fluorescent stereomicroscope. For high-magnification images, eyes were mounted in Halocarbon 700 oil (Sigma, St. Louis) and were captured with a Zeiss AxioCam HRc camera on the Zeiss Axioscope microscope.

Three- to 5-day-old adults of the appropriate genotype from each cross (in some experiments following thorax measurement) were placed on a slide containing a thin layer of silicone vacuum grease (Beckman, Fullerton, CA) and mounted in Halocarbon 700 oil under a coverslip supported by capillary tubes. Eyes were photographed using a Leica DFC420 camera mounted on a Leica M205 FA stereomicroscope. The Leica Application Suite software and ImageJ software ([rsb.info.nih.gov/ij/](rsb.info.nih.gov/ij/)) were used to analyze merged Z-stacks taken on the Leica M205 FA microscope. Only eyes with borders and head capsules in the same optical section were analyzed. At least 10 females and (or) males from a given cross were measured to obtain the average for each genotype. Eye area measurements are consistent across independent experiments ([Figure S1](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/FigureS1.pdf)).

Thorax measurement {#s13}
------------------

Thorax lengths (the distance from the base of the most anterior humeral bristle to the posterior tip of the scutellum) were measured using a Nikon SMZ-2B microscope equipped with a mechanical stage and a built-in micrometer.

Wing measurement {#s14}
----------------

For each cross 5 healthy virgin females from both the dpp-Gal4 and the en-Gal4 stocks were mated with 5--10 healthy males from w1118 (control), WT-24, and M-1 stocks. Flies of the appropriate genotype were incubated in 70% ethanol for at least 24 hr. Wings were mounted in Aqua PolyMount (Polysciences, Warrington, PA) on a glass slide. Only wings that had been flattened during the mounting process were used for further analysis. Images were captured using a Zeiss Axioscop microscope equipped with an AxioCam HRc camera and imported into ImageJ for analysis. Wing sizes in the case of the en-Gal4 driver were quantified by measuring the posterior area divided by total wing area. Wing sizes in the case of the dpp-Gal4 driver were quantified by measuring the area of sectors L4 and L3 area divided by the area of sectors L2--L4. Significance was determined by the Mann--Whitney *U*-test.

Bristle count {#s15}
-------------

Three- to 5-day-old flies of the appropriate genotype (25 males and 25 females) were placed in Halocarbon 700 oil. The presence or absence of 26 bristles (macrochaetae; [Figure S2](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/FigureS2.pdf)) on the notum, including humeri, was scored.

Results {#s16}
=======

Transgene analysis {#s17}
------------------

We generated transgenic flies carrying a single copy of either wild-type or mutant human preproinsulin (hINS^WT^ and hINS^C96Y^, respectively), whose expression is regulated by a UAS:Gal4 promoter. A total of 27 independent transgenic stocks were produced, 8 carrying hINS^WT^ and 19 carrying hINS^C96Y^, allowing us to investigate and control for position effects on gene expression. The hINS^WT^ lines also gave us the ability to identify mutation-dependent phenotypes in hINS^C96Y^ distinct from those resulting from both protein overexpression and/or interactions with native *Drosophila* insulin-like peptides (DILPs)-dependent pathways.

We investigated disease phenotypes by expressing transgenic hINS in imaginal discs of the eye (GMR-Gal4 driver), wing (en-Gal4 and dpp-Gal4 drivers), and notum (ap-Gal4 driver). The eye system was studied in greater detail than the others. GMR-Gal4 directs hINS transgene expression to developing photoreceptor neurons and surrounding support eye cells in the eye-morphogenetic furrow (<http://flystocks.bio.indiana.edu/Reports/9146.html>) ([@bib19]). We confirmed transgene expression in F~1~ adult heads by qRT-PCR (data not shown) and the presence of hINS protein in late third instar larval imaginal discs of GMR-Gal4/UAS-hINS^C96Y^ (or UAS-hINS^WT^) individuals by immunofluorescent staining with an antibody specific for hINS C peptide ([Figure 1, I--L](#fig1){ref-type="fig"}).

![Eye phenotypes induced by hINS^C96Y^ transgene expression. (A--D) Eyes of 3- to 5-day-old adults. (A) Female, GMR-Gal4. (B) Female, GMR-Gal4/UAS-hINS^WT^. (C) Female, GMR-Gal4/UAS-hINS^C96Y^. (D) Male, GMR-Gal4/UAS-hINS^C96Y^. (E--H) High-magnification images of adult eyes in A--D showing defects in patterning of ommatidia and mechanosensory bristles. (I--L) Eye-antennal imaginal discs of third instar larvae of genotypes noted in A--D stained with anti-human C-peptide antibody (red). (M--P) Discs in I--L stained with anti-ELAV antibody (green). Insets in M--P show enlarged area of the most posterior part of the eye disc.](539fig1){#fig1}

We then examined the adult eye phenotypes caused by the mutant transgene expression in comparison to controls. Adult GMR-Gal4 flies and GMR-Gal4/UAS-hINS^WT^ flies from all 8 independent transgenic lines exhibited phenotypically wild-type eyes. In contrast, 11 of 19 independent transgenic lines of the mutant hINS (GMR-Gal4/UAS-hINS^C96Y^) exhibited eye defects, including a reduction in eye area, a reduced number of eye bristles, the presence of lesions with no evidence of cells, and the collapse of ommatidial structure and normal array pattern.

The C96Y mutation is both necessary and sufficient to cause the eye degeneration phenotype. Insertion site position effect is known to influence transgene expression. We investigated whether the hINS^WT^ lines might, by chance, be lower expressing than the hINS^C96Y^ lines and for this reason not be exhibiting a defective eye phenotype. hINS transcript levels were quantified by qRT-PCR from total RNA of late third instar larval eye-imaginal discs from two mutant hINS lines, one exhibiting a mild eye phenotype (M-101) and the other a more severe eye phenotype (M-1), and from two wild-type hINS lines (WT-24 and WT-6), both of which exhibited wild-type eyes ([Figure 2A](#fig2){ref-type="fig"}). We did observe significant differences in transgene mRNA expression, but also found that WT-24 and M-1 expressed the transgenes at similar levels. We could reject, therefore, the formal possibility that the eye degeneration phenotype in the mutant is the result of gene expression alone: it requires mutant insulin. Moreover, a single copy of mutant hINS transgene (line M-1) is sufficient to cause eye degeneration (*i.e.*, GMR-Gal4/UAS-hINS^C96Y^ or GMR\>\>hINS^C96Y^/CyO). Because mutant hINS line M-1 has a strong eye degeneration phenotype and the wild-type hINS control WT-24 expresses the transgene at a similar level, subsequent analyses were carried out, comparing these two lines.

![Gene expression in eye-antennal imaginal discs of third instar larvae. (A) Relative mRNA levels in discs from larvae expressing wild-type (WT) and mutant (M, hINS^C96Y^) human proinsulin. WT-6, WT-24, M-101, and M-1 are independent transgenic lines. Gene expression is normalized to the expression level of *rp49*. The values (mean ± SE) are shown relative to the ratio for female WT-6, set to one. (B) Heat maps of expression profiles in rows (genes) and columns (lines × sex) for top 514 genes based on ANOVA between WT-24 and M-1 and the GMR-Gal4 control line are compared. ANOVA was performed for the three genotypes, two sexes, and two replicates according to the model *y = u +G + S + G* × *S*, where *G* is the genotype and *S* is gender. Each gene was tested individually. A list of 514 genes was selected to control FDR \< 5%. Each row is scaled to have mean 0 and variance 1. (C) Venn diagram showing the number of differentially expressed genes (up and down) in males and females in the comparison of WT-24 and M-1.](539fig2){#fig2}

The M-1 line exhibits a stronger eye degeneration phenotype than the M-101 line, and it expresses ∼2.5 times more transcript in late third instar imaginal discs ([Figure 2A](#fig2){ref-type="fig"}). To further investigate the relationship between mutant hINS gene expression and the severity of disease, we set up crosses to manipulate gene dosage, allowing us to compare flies bearing either one or two copies of the hINS^C96Y^ transgene and either one or two copies of the GMR-Gal4 driver transgene ([Figure 3](#fig3){ref-type="fig"}). The mutant phenotype is dramatically enhanced in double dose (w; GMR\>\>hINS^C96Y^/GMR\>\>hINS^C96Y^) compared to single dose (w; GMR\>\>hINS^C96Y^) and is more severe in males than in females. In contrast, GMR-Gal4 gene dose has no measurable effect on the severity of the eye degeneration phenotype in flies expressing one copy of hINS^C96Y^ and a small (but statistically significant) effect in flies carrying two doses of hINS^C96Y^. All the subsequent experiments here and in an accompanying article in this issue ([@bib30]) are with flies carrying a single copy of mutant hINS.

![Eye degeneration in response to GMR-Gal4 and hINS^C96Y^ gene dose. The eye degeneration phenotype is much more sensitive to mutant insulin gene dose than to GMR-Gal4 dose. All four possible combinations of two-locus genotypes (one or two copies of either GMR-Gal4 or hINS^C96Y^) were produced and adult eye areas measured separately for the two sexes, as described in *Materials and Methods*. (A) Representative adult eyes and the genotype abbreviations for the dosage series. (B) Box plot of eye area (*N* = 10 for each genotype/sex). Significance was determined by Student's two-tailed *t*-test. Genotype abbreviations: 1G 1hI \[F, M\]: w; GMR\>\>hINS^C96Y^ \[Female, Male\]; 2G 1hI \[F, M\]: w; GMR\>\>hINS^C96Y^/GMR-Gal4 \[Female, Male\]; 1G 2hI \[F, M\]: w; GMR\>\>hINS^C96Y^/UAS-hINS^C96Y^ \[Female, Male\]; 2G 2hI \[F, M\]: w; GMR\>\>hINS^C96Y^/GMR\>\>hINS^C96Y^ \[Female, Male\].](539fig3){#fig3}

Eye phenotype {#s18}
-------------

The adult eye in GMR-Gal4/UAS-hINS^C96Y^ flies display a number of characteristic defects, most notably a reduction in size. Individual ommatidia are often collapsed, lacking the wild-type organization of photoreceptor cells, giving the eye a glassy punctate phenotype ([Figure 1, C and D](#fig1){ref-type="fig"}). The regular array structure of ommatidia across the eye field is also disrupted, with the individual hairs projecting from each one either disarrayed or absent ([Figure 1, G and H](#fig1){ref-type="fig"}). Finally, black lesions can be present within the eye field where no cellular structure is evident ([Figure 1, D and H](#fig1){ref-type="fig"}).

The GMR-Gal4 driver activates expression in the cells posterior to the morphogenetic furrow in the eye discs ([@bib19]). We therefore examined the organization and cellular structure of developing ommatidia by costaining eye imaginal discs from wandering third instar larvae with anti-human C-peptide (a marker of proinsulin expression) ([@bib55]) and an antibody against ELAV, a neuron-specific RNA-binding protein widely used to stain rhabdomeres ([@bib58]). This allowed us to confirm expression of wild-type and mutant proinsulin in the developing eye field ([Figure 1, K and L](#fig1){ref-type="fig"}). Ommatidial arrays at this early stage of eye formation are irregular and disorganized ([Figure 1, O and P](#fig1){ref-type="fig"}), indicating that the adult reduced-eye phenotype originates in the eye morphogenetic furrow with improper formation and maturation of photoreceptor cells, ommatidia, and ultimately the entire eye field.

The severity of the reduced-eye phenotype differs quantitatively between the two sexes. Mutant males in GMR-Gal4/UAS-hINS^C96Y^ flies exhibit a measurably stronger, *i.e.*, more degenerate, eye phenotype than females \[[Figure 1, C and G](#fig1){ref-type="fig"} (female) *vs.* [Figure 1, D and H](#fig1){ref-type="fig"} (male)\], a difference that is independent of gene dose, temperature, and genetic background ([@bib10]). This difference cannot be attributed to sex-specific difference in hINS expression, which does not differ significantly in the eye imaginal discs of either wild-type or mutant hINS lines ([Figure 2A](#fig2){ref-type="fig"}). The male-biased phenotype, moreover, is not restricted to eye development; it is also observed in the notum and the wing when hINS^C96Y^ is expressed in the developing wing imaginal disc under the control of three other Gal4 drivers, as described below. The sex-biased phenotype appears to arise, therefore, not through tissue-specific development, but rather through a gender difference in cellular response to the mutant proinsulin protein.

Transcriptional profiles in eye imaginal discs expressing wild-type and mutant hINS {#s19}
-----------------------------------------------------------------------------------

To investigate the effect of expressing hINS^C96Y^ on genome-wide transcription profiles and to identify the key changes in expression underlying the disease phenotype, we characterized gene expression profiles of RNA prepared from wandering third instar eye imaginal discs with the Affymetrix-GeneChip *Drosophila* Genome 2.0 Array. Imaginal discs were isolated from F~1~ larvae carrying one copy of a GMR-Gal4 driver and one copy of either a wild-type or a mutant hINS transgene. As a control, we measured gene expression in a GMR-Gal4 × w1118 cross. The experiments included two independent transgenic lines each for hINS^WT^ and hINS^C96Y^, including the matched pair WT-24 and M-1 shown to express hINS mRNA at similarly high levels ([Figure 2A](#fig2){ref-type="fig"}). We first compared expression profiles between the GMR-Gal4 × w1118 control and hINS^WT^- and hINS^C96Y^-expressing lines. After accounting for sex differences, we found no evidence for any effect on gene expression by wild-type hINS: there were no significant gene differences between the GMR-Gal4 control line and WT-6 and only a single difference in WT-24 at an FDR \< 0.10 level ([Figure S3](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/FigureS3.pdf)). In contrast, 124 and 232 genes differed in males and females (respectively) between the mutant hINS lines and the GMR-Gal4 control. Thus, the effect on global gene expression caused by transgene expression can therefore be entirely attributed to the mutant proinsulin expression.

To visually illustrate the similarity and difference in gene expression between the control cross and hINS^WT^-expressing and hINS^C96Y^-expressing lines, we fitted an ANOVA model to each gene for three genotypes (GMR-Gal4 × M-1; GMR-Gal4 × WT-24; GMR-Gal4 × w1118), accounting for sex effects (see *Data analysis 2* in *Materials and Methods*), in which we identified 514 probe sets with significant genotype differences ([File S2](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/FileS2.xlsx)). A heat map ([Figure 2B](#fig2){ref-type="fig"}) illustrates the similarities between the transcription profiles of hINS^WT^ and the control and confirms at the molecular level the lack of a visible phenotype caused by hINS^WT^ expression. It also highlights the reorganization of transcription induced by hINS^C96Y^ expression.

We then analyzed differences in gene expression between GMR-Gal4 × WT-24 and GMR-Gal4 × M-1, because these two crosses had a matching, high level of expression of the transgenes. We found 297 genes whose expression differed in males (189 upregulated and 108 downregulated) and 109 genes that differed in females (81 upregulated and 28 downregulated) ([Figure 2C](#fig2){ref-type="fig"}; [File S1](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/FileS1.xlsx)). Of these, 91 overlapped between males and females (70 upregulated and 21 downregulated).

Inspection of the genes whose expression changed in response to mutant hINS revealed genes involved in protein folding/modification, protein degradation, and defense response/programmed cell death ([Table 2](#t2){ref-type="table"}; [Table S2](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/TableS2.pdf) and [Table S3](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/TableS3.pdf)) and included representatives in UPR and ER-associated degradation (ERAD) pathways. An unbiased and unsupervised clustering analysis using David tools for Gene Ontology (GO) terms showed the greatest enrichment in membrane-bound proteins, while heat-shock proteins were also enriched ([Table S4](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/TableS4.pdf)).

###### Selected genes upregulated by GMR-Gal4/UAS-hINS^C96Y^ in male eye imaginal discs

  Probe set                                           Transcript   Name              Description (GO)[*^a^*](#t2n1){ref-type="table-fn"}   Homolog[*^b^*](#t2n2){ref-type="table-fn"}
  --------------------------------------------------- ------------ ----------------- ----------------------------------------------------- --------------------------------------------
  Protein modification/folding                                                                                                             
   1639033_at[*^c^*](#t2n3){ref-type="table-fn"}      CG9432-RB    l(2)01289         Disulfide isomerase                                   
   1623862_at[*^c^*](#t2n3){ref-type="table-fn"}      CG3966-RA    ninaA             HSP[*^d^*](#t2n4){ref-type="table-fn"}                
   1628660_at[*^c^*](#t2n3){ref-type="table-fn"}      CG7130-RA    CG7130            HSP[*^d^*](#t2n4){ref-type="table-fn"} binding        DNAJB1
   1623247_at[*^c^*](#t2n3){ref-type="table-fn"}      CG10420-RA   CG10420           HSP[*^d^*](#t2n4){ref-type="table-fn"}                SIL1
   1627525_a\_at                                      CG1333-RA    Ero1L             Thiol-disulfide exchange                              ERO1LB
   1641511_at                                         CG7394-RA    TIM14             HSP[*^d^*](#t2n4){ref-type="table-fn"} binding        DNAJC19
   1641563_at                                         CG8286-RA    P58IPK            HSP[*^d^*](#t2n4){ref-type="table-fn"} binding        DNAJC3
   1634528_at                                         CG8412-RA    CG8412            Glycosyltransferase                                   ALG12
   1638456_at                                         CG8531-RA    CG8531            HSP[*^d^*](#t2n4){ref-type="table-fn"} binding        
  Protein degradation                                                                                                                      
   1632071_at                                         CG8870-RA    CG8870            Serine-type endopeptidase activity                    
   1637515_s\_at[*^c^*](#t2n3){ref-type="table-fn"}   CG1512-RA    Cullin-2          Ubiquitin-protein ligase                              CUL2
   1626272_s\_at[*^c^*](#t2n3){ref-type="table-fn"}   CG3066-RA    Sp 7              Peptidase                                             SP7
   1626460_at                                         CG2658-RA    CG2658            Peptidase                                             SPG7
   1635051_a\_at                                      CG14536-RA   Herp              Ubiquitin-protein ligase                              HERPUD2
   1634486_at                                         CG30047-RA   CG30047           Peptidase                                             
   1624372_at                                         CG10908-RA   Derlin-1          Peptidase                                             DERL1
   1637955_a\_at[*^c^*](#t2n3){ref-type="table-fn"}   CG1827-RA    CG1827            Lysosome                                              
   1625253_at                                         CG4909-RA    POSH              Ubiquitin-protein ligase                              SH3RF1
   1623029_at                                         CG31535-RA   CG31535           Ubiquitin-protein ligase                              
   1634899_a\_at                                      CG6512-RA    CG6512            Peptidase                                             AFG3L2
  Defense response/programmed cell death                                                                                                   
   1636668_at                                         CG9972-RA    CG9972            Apoptosis[*^e^*](#t2n5){ref-type="table-fn"}          
   1624450_at                                         CG6331-RA    Orct              Apoptotic process                                     
   1633145_at                                         CG4437-RA    PGRP-LF           Apoptosis[*^e^*](#t2n5){ref-type="table-fn"}          PGLYRP3
   1622979_a\_at                                      CG7188-RB    Bax inhibitor-1   Apoptosis[*^e^*](#t2n5){ref-type="table-fn"}          
   1641298_at                                         CG10535-RA   Elp1              Defense response                                      
   1634714_at                                         CG1676-RA    Cactin            Defense response                                      C19orf29
   1635028_s\_at                                      CG33047-RA   Fuca              Defense response                                      FUCA2
   1638100_s\_at                                      CG1228-RD    Ptpmeg            Apoptotic process                                     PTPN4
   1628174_at                                         CG33119-RA   nim B1            Defense response                                      

GO molecular function/process from <http://www.flybase.org>, [www.uniprot.org](http://www.uniprot.org), and <http://david.abcc.ncifcrf.gov>.

Human homolog from <http://flight.icr.ac.uk>.

Upregulated in female and male.

Heat-shock protein.

Negative regulation.

Although we did not observe a significant difference in the mRNA levels of the upstream regulators of the UPR \[IRE1, PEK (PERK), Hsc70-3 (BiP; GRP78), and XBP1\] in the GeneChip analysis, a more sensitive analysis by qRT-PCR in male eye imaginal discs expressing mutant hINS compared to the GMR-Gal4 control revealed significant increases in expression of PERK (CG2087), BiP (CG4147), and XBP1 (CG9415) and a nearly significant increase in expression of IRE1 (CG4583; *P* = 0.08) ([Table S5](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/TableS5.pdf)). As a more definitive test for activation of UPR, we also examined XBP1 mRNA for UPR-associated splicing by IRE1 and found evidence for it in mutant hINS-expressing cells but not in wild-type or GMR-Gal4-expressing cells ([Figure S4](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/FigureS4.pdf)). To confirm the microarray data by an independent method, we validated expression levels in the five lines (GMR-Gal4, WT-6, WT-24, M-101, and M-1) for five genes sets (CG3966, CG7130, CG10420, CG10160, and CG9150) whose expression was upregulated in males ([Figure 2C](#fig2){ref-type="fig"}). The results showed excellent correspondence between microarray and qRT-PCR ([Table S6](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/TableS6.pdf)).

Expression of wild-type and mutant hINS in the notum and wing {#s20}
-------------------------------------------------------------

Expression of mutant (but not wild-type) hINS in the notum, driven with an apterous driver (ap-Gal4), causes a reduction in the posterior margin of the notum and a loss of macrochaetae ([Figure 4, C and D](#fig4){ref-type="fig"}). The adult fly notum has 22 macrochaetae ([Figure S2](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/FigureS2.pdf)), which in ap\>\>hINS^C96Y^ flies is reduced by an average of 8.3 and 13.4 bristles in females and males, respectively ([Table S7](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/TableS7.pdf)). This 40% sex differential in bristle loss does not appear to be intrinsic to development---as a control we found no sex difference in bristle loss in the classic developmental mutant Scutoid (Sco) ([@bib20]), which suppresses notum bristles to approximately the same extent as mutant hINS expression, but does so to an equal extent in both sexes ([Table S7](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/TableS7.pdf)).

![Notum and wing phenotypes induced by hINS^C96Y^ transgene expression. (A--J) Notum (A--D) and wing (E--J) phenotypes in 3- to 5-day-old adults of indicated sex and genotype. Insets show a higher-magnification view of the anterior or posterior crossvein (ACV) with the *campaniform sensillae* shown by an arrow. Note the missing anterior crossvein in G (dpp-Gal4 driver), the partial anterior crossvein and abnormal posterior crossvein in J (en-Gal4 driver), and the relocation of the *companiform sensillae* from the anterior crossvein to the longitudinal vein in J.](539fig4){#fig4}

Expression of mutant (but not wild-type) hINS in the developing wing imaginal disc causes visible defects in a proportion of adult wings ([Figure 4, E--J](#fig4){ref-type="fig"}). dpp-Gal4 drives expression in cells adjacent to the border of the posterior and anterior wing compartments; en-Gal4 drives expression only in the posterior wing compartment. In dpp-Gal4/UAS-hINS^C96Y^ flies, either the distal margins of ∼30% of wings are scalloped or the anterior crossvein (ACV) is absent, both phenotypes being restricted to the domain where mutant proinsulin is predicted to be expressed. Expression of mutant hINS by the en-Gal4 driver results in occasional partial loss of ACV along its posterior boundary, also corresponding to the predicted region of mutant protein expression. Wing scalloping and ACV loss are striking phenocopies of the classical mutants *[Notch](http://flybase.org/reports/FBgn0004647.html)* (incision of wing margin) and *[crossveinless](http://flybase.org/reports/FBgn0000394.html)*, respectively, both regulators of wing development. Portions of the adult wing corresponding to mutant hINS expression in the wing imaginal disc are also significantly reduced in area ([Figure 5](#fig5){ref-type="fig"}).

![Expression of hINS^C96Y^ in different compartments produces a nonallometric reduction in wing size. (A and C) Control wings showing the regions used to quantify the effects of hINS^C96Y^ expression. The red line denotes the border between the anterior (above) and posterior (below) compartments of the wing. en-GAL4 expresses in the posterior compartment. The five longitudinal wing veins are labeled L1--L5. The L2--L4 intervein sector is shadowed in green. dpp-GAL4 expresses in the L3--L4 intervein sector. (B) en genotypes: en-Gal4 (*n* = 13), en-Ga4/UAS-hINS^WT^ (*n* = 13), and en-Gal4/UAS-hINS^C96Y^ (*n* = 13). Values represent the ratio of the posterior wing compartment divided by the total wing area. (D) dpp genotypes: dpp-Gal4 (*n* = 10), dpp-Gal4/UAS-hINS^WT^ (*n* = 10), and dpp-Gal4/UAS-hINS^C96Y^ (*n* = 11). Values represent the ratio of the L3--L4 intervein sector divided by the L2--L4 intervein sector area. NS, not significant, Mann--Whitney *U*-test.](539fig5){#fig5}

Mechano-sensory structures on the wing---the campaniform sensillae---can also be absent in portions of the wing where mutant hINS is expressed under the control of the dpp- and en- drivers ([Figure S5](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/FigureS5.pdf)). One such sensilla lies along the anterior portion of the ACV and is typically absent when that portion of the crossvein is missing in en-Gal4/UAS-hINS^C96Y^ flies. In dpp-Gal4/UAS-hINS^C96Y^ flies, three additional sensillae sitting along the distal portion of the longitudinal wing vein 3 can also be absent ([Table S8](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/TableS8.pdf)).

Mutant proinsulin expression in the developing wing also causes misspecification of cell fates to produce both ectopic wing veins and campaniform sensillae. The en-Gal4 driver, in particular, produces the novel appearance of both veins and sensillae ([Figure 4J](#fig4){ref-type="fig"}). A sensilla sitting along the ACV, when absent in en-Gal4/UAS-hINS^C96Y^ wings, is often replaced with an ectopic one appearing more anteriorly along the ACV or along the radial wing vein proximal to where it is intersected by the ACV. The posterior wing crossvein in the mutant can also project ectopic longitudinal veins.

hINS^C96Y^-induced phenotypes are modified by genetic background {#s21}
----------------------------------------------------------------

The eye, wing, and notum are notable examples of developmentally canalized structures that generally become more variable in a mutant background. Consistent with this observation, the mutant hINS-induced eye phenotype displays sensitivity to temperature and differs between the two sexes. In crosses involving the third chromosome balancer TM3, we also observed more severe eye phenotypes when the balancer chromosome was present ([@bib10]), indicating sensitivity to the genetic background. We therefore examined the extent to which naturally occurring genetic variation modifies the mutant hINS phenotype in the eye and notum. We crossed a tester stock carrying the mutant transgene (M-1) and either the GMR-Gal4 or ap-Gal4 driver on the same second chromosome (GMR\>\>hINS^C96Y^ or ap\>\>hINS^C96Y^) with 38 reference inbred lines derived from a single population collection, the DGRP ([@bib46]), and measured eye phenotypes or counted dorsal macrochaetae in F~1~ adults. The F~1~ males in the crosses carried an identical X chromosome---the tester chromosome. The screen, therefore, revealed only partially or fully dominant autosomal modifiers of the mutant phenotype. For each cross we measured eye area or dorsal bristle number in a minimum of 10 individuals of each sex.

### Eye phenotypes: {#s22}

The crosses revealed highly heritable genetic variation \[*h*^2^ (males) = 0.732; *h*^2^ (females) = 0.657\], visible as a nearly continuous distribution of between-line differences in eye degeneration phenotypes, ranging from nearly wild-type to highly reduced and slit-like eyes ([Figure 6, A and C](#fig6){ref-type="fig"}). These interline differences are not correlated with each line's body size \[bivariate fit of eye area with thorax length, *r*^2^ = 0.0051 ([@bib10])\] or eye area ([Figure S6](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/FigureS6.pdf)) or with the quantity of Gal4 protein, which did not vary significantly ([Figure S7](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/FigureS7.pdf)). There are also significant between-line differences in other aspects of the eye phenotype, including aspect ratio (width:height), ommatidial degeneration, and prevalence of lesions ([@bib10]). Lesion prevalence, unlike aspect ratio or ommatidial degeneration, was not significantly correlated with the extent of eye loss (*r*^2^ = 0.01), indicating the two have independent genetic underpinnings rather than being the consequence of pleiotropy.

![Genetic variation for hINS^C96Y^-induced degeneration in the adult eye and notum. (A) Variation in eye area in F1 adults from crosses between the GMR»hINS^C96Y^ tester strain and 38 DGRP lines described in *Materials and Methods*. (B) Variation in bristle number in F1 adults from crosses between the ap»hINS^C96Y^ tester strain and 38 DGRP lines. (C and D) Eye area and bristle number. The data are displayed from left to right by decreasing severity of phenotypes. Eye area (mean ± SE) for a wild-type control (GMR-Gal4 × w1118) is shown on the far right in solid circles (in C, only male wild-type eye areas are shown). (E) Correlation between bristle loss and eye area reduction (male, Spearman's rank correlation *ρ* = −0.23, P = 0.16; female, *ρ* = −0.17, P = 0.30).](539fig6){#fig6}

### Notum phenotypes: {#s23}

As with the eye phenotype, we found significant interline variation ranging from lines with nearly wild-type bristle number (RAL-427, 25.6 ± 0.7) to ones missing a majority of bristles (RAL-335, 11.0 ± 1.1) and with a high heritability \[*h*^2^(males) = 0.744\] ([Figure 6D](#fig6){ref-type="fig"}; [Table S11](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/TableS11.pdf)).

Disease traits are uncorrelated {#s24}
-------------------------------

We reasoned that if the genetic pathways responding to hINS^C96Y^ expression common to both eye and notum, such as UPR, harbor modifiers of the response, then the severity of the eye reduction and bristle loss should be positively correlated in the sample of DGRP lines. To ask whether the same modifiers are acting in a similar manner in both tissues we measured the correlation between traits in the 38 lines for which both were measured. Surprisingly, we found no evidence for a positive correlation ([Figure 6E](#fig6){ref-type="fig"}; [Table S9](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/TableS9.pdf); male, Spearman's rank correlation *ρ* = −0.23, *P* = 0.16; female, *ρ* = −0.17, *P* = 0.30). Either the common response pathways harbor little of the genetic variation for the disease phenotypes or their penetrance must be modulated by tissue-specific factors.

Variation in eye-specific genetic pathways is uncorrelated with hINS^C96Y^-induced phenotypes {#s25}
---------------------------------------------------------------------------------------------

The lack of correlated mutant hINS-induced phenotypes in the eye and notum raises an alternative possibility that genetic variation acts not through shared response pathways but rather through tissue-specific developmental pathways and in so doing "releases" pathway-specific genetic variation otherwise suppressed in the wild type. To test this possibility, we examined genetic variation in the DGRP lines for two eye-development-specific genetic mutations, *[Lobe](http://flybase.org/reports/FBgn0001332.html)* (*[L](http://flybase.org/reports/FBgn0001332.html)*) and *[Drop](http://flybase.org/reports/FBgn0000492.html)* (*[Dr](http://flybase.org/reports/FBgn0000492.html)*). *[L](http://flybase.org/reports/FBgn0001332.html)* and *[Dr](http://flybase.org/reports/FBgn0000492.html)* are classic dominant eye-degeneration mutations that can be crossed to the DGRP lines in the same manner as the mutant proinsulin transgene to reveal dominant genetic variation for reduced-eye phenotypes. *[L](http://flybase.org/reports/FBgn0001332.html)* encodes the ortholog of mammalian PRAS40 and regulates eye development through TORC1 signaling ([@bib76]); mutants display an apoptotic reduced-eye phenotype. *[L](http://flybase.org/reports/FBgn0001332.html)* acts through the Jak/Stat signaling pathway in the ventral eye, possibly interacting with the *[Notch](http://flybase.org/reports/FBgn0004647.html)* ligand, *[Serrate](http://flybase.org/reports/FBgn0004197.html)* ([@bib14]). *[Dr](http://flybase.org/reports/FBgn0000492.html)*, in contrast, is a muscle segment homeobox-1 (*msh*) transcription factor that regulates interaction between epithelial and mesenchymal cells. It is active in embryonic neural dorsal--ventral patterning and again in eye development. *[Dr](http://flybase.org/reports/FBgn0000492.html)* mutants ectopically express *msh*, blocking morphogenetic furrow progression in the developing eye, leading to apoptotic photoreceptor cell loss and a nearly eyeless phenotype ([@bib49]).

The genetic variation exposed by mutant hINS expression appears to be distinct from the genetic variation exposed by eye development mutants despite its apparent tissue specificity. We crossed *[L](http://flybase.org/reports/FBgn0001332.html)*, *[Dr](http://flybase.org/reports/FBgn0000492.html)*, and hINS^C96Y^ to 38 DGRP lines and collected F~1~ adults for eye area measurement. Variation in hINS^C96Y^-induced eye degeneration was comparable to previous measurements in the same lines ([Figure 7, A and D](#fig7){ref-type="fig"}; [Figure S1](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/FigureS1.pdf) and [Figure S8](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/FigureS8.pdf); [Table S10](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/TableS10.pdf) and [Table S11](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/TableS11.pdf)). F~1~ flies displayed heritable variation for both *[Dr](http://flybase.org/reports/FBgn0000492.html)* and *[L](http://flybase.org/reports/FBgn0001332.html)* phenotypes, which when scaled by their within-line variances displayed a range of phenotypes similar to hINS^C96Y^ flies ([Figure 7, A and B](#fig7){ref-type="fig"}). There is no significant correlation between any pair of traits ([Figure 7C](#fig7){ref-type="fig"}; [Table S9](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/TableS9.pdf)) and thus no evidence for shared variation acting on mutant hINS and two eye-development-specific mutants. It is also worth noting that for both *[L](http://flybase.org/reports/FBgn0001332.html)* and *[Dr](http://flybase.org/reports/FBgn0000492.html)*, eye area in males is ∼85% that of females, consistent with the difference in wild-type flies. In contrast, eye area in males of mutant proinsulin-expressing crosses is 50% that of females, indicating a sex-specific input to the disease phenotype (also see [Figure 6, C and D](#fig6){ref-type="fig"}).

![Genetic variation for eye area reduction in F~1~ adults from crosses between GMR\>\>hINS^C96Y^, *Drop*, or *Lobe* and 38 DGRP lines. (A) Range of phenotypes in F~1~ adults in both sexes. (B) Deviation (in units of within-line SD) of each line mean from the overall mean within each of the three sets of crosses. (C) Correlation of eye area reduction between hINS^C96Y^ and *Dr* (open circles) or *L* (solid circles) × DGRP F~1~ males. (D) Box plots showing the unscaled distribution of phenotypes in the three sets of crosses \[thick line, median; box, 25th and 75th percentiles; whisker, 1.5 interquartile range (IQR); circles, data outside the 1.5 IQR\].](539fig7){#fig7}

Discussion {#s26}
==========

*Drosophila* is a useful model for studying cell function and development in response to misfolded proinsulin. We show that mutant (but not wild-type) hINS expression causes a reduction in size (and cell number for eyes) in every tissue examined. Human proinsulin is not processed to insulin in developing eye cells, but can be induced to do so by overexpressing a secretory cell master regulator, the bHLH transcription factor DIMMED ([@bib56]). Consistent with this result, we observed no effect of wild-type hINS expression on gene expression or eye development. Although we have not established a specific mechanism (or mechanisms) by which mutant-induced eye reduction occurs, one of them is likely to involve UPR, which we show is induced based on both the presence of XBP1 alternatively spliced mRNA in eye imaginal discs expressing hINS^C96Y^ and the induction of well-known stress response genes, including those aiding protein folding and promoting programmed cell death. We also establish a reorganization of gene expression in imaginal disc cells in response to mutant hINS expression.

Cell death in the *Drosophila* model recapitulates a key feature of disease observed in mouse diabetes caused by the same C96Y mutation in *Ins2*: the dominant loss of insulin-secreting β-cells ([@bib81]; [@bib73]). In the mouse model, the synthesis of misfolded proinsulin leads to its retention in the ER, resulting in induction of UPR, death of the insulin-secreting pancreatic β-cells, and diabetes ([@bib64]; [@bib69]). The human form of hINS^C96Y^-induced disease is believed to act through the same mechanism ([@bib41]; [@bib55]); based on our gene expression experiment, this may hold true in the *Drosophila* model as well.

Developing tissues, we discovered, are more sensitive to mutant hINS expression in males than in females. When expressed in the eye, hINS^C96Y^ causes a nearly twofold reduction in eye area in males compared to females. Other features of the eye, including the presence of necrotic lesions, photoreceptor cell collapse, and ommatidial disorganization, are also more evident in males. *[L](http://flybase.org/reports/FBgn0001332.html)* and *[Dr](http://flybase.org/reports/FBgn0000492.html)* in contrast, although also producing reduced-eye phenotypes, do not exhibit sex-specific differences relative to wild type. The flexibility of the *Drosophila* model allowed us to establish that the notum also displays a differential male sensitivity to mutant hINS expression. We believe, therefore, that the greater sensitivity to mutant hINS in males must involve cell physiology rather than tissue-specific development. We can entertain at least two hypotheses for the male sensitivity, both of which are potentially testable. One obvious possibility involves disruption of dosage compensation. In *Drosophila*, dosage compensation occurs in males by upregulating X-linked genes through the activity of the male sex-lethal (MSL) complex ([@bib21]). Reorganization of gene expression in stressed cells may disrupt maintenance of dosage compensation, leading to the exacerbation of cellular stress and cell death in males. An alternative hypothesis posits that cells in males are less well canalized against perturbation, such as with expression of mutant hINS, perhaps because dosage compensation introduces greater variability in X-linked gene expression. It is well known, for example, that the effectiveness of dosage compensation varies quantitatively across X-linked genes and is complete in only a subset of them ([@bib27]). Cell-to-cell or temporal variation in X-linked gene expression might increase demand on the homeostatic mechanisms involving proteostasis. It should be possible to test these hypotheses by genetically manipulating flies to examine sex determination, dosage compensation, or sex differentiation pathway contributions to male-biased disease. More generally, fly models of human disease, such as ours, may be valuable in disentangling environmental and genetic contributions to sex differences in susceptibility or severity of disease, a notoriously difficult problem in human studies.

Male sex bias may be a general property of the disease: it is also a feature of diabetes in mice ([@bib73]). Male mice heterozygous for *Ins2^C96Y^* develop diabetes at an earlier age than females ([@bib52]). In the fly, X-linked genes are upregulated in males whereas in mammals a single X chromosome is inactivated in female cells. If the mechanism underlying the male bias in fly and mouse is the same, it is unlikely, therefore, to directly involve dosage compensation.

A second unexpected finding was the presence of fully differentiated ectopic veins and sensory structures in wings expressing mutant hINS. These same wings also display loss-of-structure phenotypes, including crossveins and campaniform sensillae, as well as scalloping of wing margins. Both ectopic gain and loss of these differentiated tissues are striking phenocopies of classical wing mutations, many of which have been shown to be involved in the regulation of wing development ([@bib50]). We believe, therefore, that mutant hINS expression can not only induce cell death, but also lead to reprogramming of cell fates. An interesting implication for the human form of the disease is that loss of β-cells in neonates may involve not only cell death but also transformation of precursor cells to other cell types.

Third, crosses to a reference panel of naturally derived lines (DGRP) revealed extensive dominant (or partially dominant) genetic variation acting to suppress or enhance cell loss. One possibility, which we investigated and could reject, is variation in mutant hINS gene expression in different DGRP backgrounds. Since all the flies carry the same tester chromosome (GMR\>\>hINS^C96Y^), we focused our attention on Gal4 instead, because its expression could be influenced by variation in transcription factors acting on its promoter, GMR; we found no evidence for differences in Gal4 protein levels between DGRP lines representative of the full range of eye degeneration phenotypes ([Figure S7](http://www.genetics.org/content/suppl/2013/11/25/genetics.113.157602.DC1/FigureS7.pdf)). GMR is a synthetic enhancer consisting of binding sites for the eye-specific transcription factor glass (*[gl](http://flybase.org/reports/FBgn0004618.html)*). In an accompanying article, we also find no evidence for association of genetic variation in or around the *[gl](http://flybase.org/reports/FBgn0004618.html)* locus with eye degeneration ([@bib30]). We do not believe, therefore, that variation in eye degeneration is caused by genetic variation in the transcription of mutant hINS.

Finding extensive genetic variation in eye degeneration in our F~1~ screen establishes the feasibility of applying methods of statistical association to identify modifiers of disease, the subject of the accompanying article ([@bib30]). Here we explored other dimensions of this variability. It is worth noting that many, if not most, Mendelian models of disease in the fly involve gain-of-function alleles, which facilitates screens for natural variation in F~1~ flies. In addition to the convenience of this genetic screen, it also eliminates phenotypes resulting from the homozygosity of deleterious alleles in inbred lines. Outcrossed genotypes are well suited for investigating low-frequency variants, which are rarely homozygous in natural populations.

Disease phenotypes in the eye and notum were not significantly correlated in the DGRP panel, suggesting that different suites of alleles are acting in the two tissues. A positive correlation would be expected if genetic variation occurred primarily in shared pathways responding to mutant hINS expression, such as UPR. Not finding evidence for such a correlation, we then investigated whether a correlation would be observed when comparing a single phenotype---eye reduction---caused by hINS and by two classical mutations, *[L](http://flybase.org/reports/FBgn0001332.html)* and *[Dr](http://flybase.org/reports/FBgn0000492.html)*. The fact that we failed to find significant correlations between either *[L](http://flybase.org/reports/FBgn0001332.html)* or *[Dr](http://flybase.org/reports/FBgn0000492.html)* and hINS^C96Y^ leaves us with a puzzling set of results: natural variation for hINS-induced disease severity exhibits tissue specificity but involves a different set of genes or alleles than the ones revealed with eye-development-specific mutants. The latter result, but perhaps not the former, should come as no surprise. In other models of Mendelian disease, *e.g.*, aggregation-prone proteins expressed in the developing eye, forward genetic screens for suppressors and enhancers of reduced eye phenotypes successfully identify genes acting in pathways known to be responsive to proteostatic stress: UPR, apoptosis, RNA-folding, peptide-folding, transit, and degradation pathways ([@bib11]; [@bib77], [@bib78]; [@bib13]; [@bib12]; [@bib7], [@bib8]; [@bib37]; [@bib39]; [@bib80]), but not regulators of eye development. As this also appears to be the case for naturally occurring variation in our Mendelian model of disease, distinct alleles and genes must be acting as modifiers, perhaps epistatically, in different tissues.

An alternative hypothesis can be constructed on the premise that the spectrum of mutations affecting this complex disease trait may have a much broader set of targets, needing only to impinge on processes involved in cellular or physiological homeostasis. Disease occurs when an individual's homeostatic "capacitance"---the ability to buffer against cellular stress---is exceeded. Whether a threshold is crossed will depend on both the cellular activities set by an individual's background genotype and the environmental demands or rare mutant alleles acting critical pathways.

Subtle effects of genetic background on the ability of a cell to balance protein synthesis, folding, transport, and degradation---*i.e.*, proteostasis---may be responsible for many diseases, in addition to diabetes. Under this hypothesis, a complex and diffuse web of interacting polymorphisms sets an individual's ability to respond to genetic or environmental challenges, determining susceptibility to and severity of disease. If true, the vast majority of mutations and the spectrum of disease-causing loci segregating in natural populations are likely to be systematically and substantially different from the strong loss- or gain-of-function alleles identified in forward genetic screens alone.

In addition, as proteomes differ between tissues, so too will the alleles affecting proteostasis. This possibility is illustrated by revealing experiments on two aggregation-prone/misfolded proteins in a worm model: polyglutamine protein ([@bib24]) and mutant SOD1 ([@bib25]). In both cases, temperature-sensitive (*ts*) mutations in housekeeping proteins, although innocuous when the worm is reared below the *ts* threshold, enhance mutant protein phenotypes, and hence toxicity, when the *ts* threshold is exceeded. SOD1 phenotypes are also sensitive to the genetic background.

*Drosophila* is an excellent model for investigating naturally occurring genetic variation for quantitative traits. The recent establishment of the DGRP ([@bib46]), of synthetic populations ([@bib32]; [@bib36]), and of other novel population resequencing approaches ([@bib72]) adds to its power and appeal. Here we extend the applicability of these approaches to the study of human disease. An important question remaining to be addressed is whether the extensive genetic variation revealed in this study of a genetically "sensitized" fly is the same as the variation underlying complex genetic forms of the disease, an issue further discussed in the accompanying article ([@bib30]). An affirmative answer to this question raises the prospect for using *Drosophila* as a model of genetically complex human disease.
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